Related Experiment Video
Updated: May 31, 2026
06:29
Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
Published on: January 29, 2014
Pathology consultation on drug-induced hemolytic anemia
Arand Pierce1, Theresa Nester,
1Puget Sound Blood Center, 921 Terry Ave, Seattle, WA 98104, USA.
American Journal of Clinical Pathology
|June 21, 2011
Summary
Drug-induced immune hemolytic anemia, though rare, is underrecognized. Distinguishing drug-dependent from drug-independent antibodies is crucial for managing this condition, with drug cessation being the primary recommendation.
Area of Science:
- Hematology
- Immunology
- Clinical Pathology
Background:
- Drug-induced immune hemolytic anemia (DIIHA) is a rare but potentially underdiagnosed condition.
- Accurate diagnosis relies on integrating serological findings with clinical history.
- Pathologists play a key role in differentiating antibody types for effective management.
Purpose of the Study:
- To highlight the importance of distinguishing between drug-dependent antibodies (DDABs) and drug-independent antibodies (DIABs) in DIIHA.
- To provide guidance on the serological characteristics and common causative agents for each antibody type.
- To emphasize the critical role of the consulting pathologist in DIIHA diagnosis and management.
Main Methods:
- Review of serological findings in DIIHA cases.
- Correlation of antibody types (DDABs vs. DIABs) with specific drug classes.
- Analysis of diagnostic features, including direct antiglobulin test (DAT) and elution studies.
- Comparison of DIAB serology with warm autoantibodies.
Main Results:
- Drug-dependent antibodies (DDABs) are frequently linked to cefotetan, ceftriaxone, and piperacillin.
- Drug-independent antibodies (DIABs) are commonly associated with fludarabine, methyldopa, beta-lactamase inhibitors, and platinum-based chemotherapeutics.
- DDABs typically show a positive DAT and negative elution.
- DIABs are serologically similar to warm autoantibodies and respond to steroids.
Conclusions:
- Proper classification of drug-induced antibodies (DDABs vs. DIABs) is essential for appropriate DIIHA management.
- Understanding the specific serological profiles aids in identifying causative agents.
- Discontinuation of the implicated drug is the recommended course of action for all DIIHA cases.
Related Concept Videos
01:16Drug toxicity: Idiosyncratic Reactions
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
01:01Hypersensitivity Reactions: Cytolytic Reactions
Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:30Drug Toxicity: Allergic Reactions
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:14Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...